IDOX PLC

Declaration of Voting Results & Voting Rights Announcements • Jul 16, 2020

National Storage Mechanism | Additional information

RNS Number : 1505T

IDOX PLC

16 July 2020

Idox plc

('Idox' or the 'Group' or the 'Company')

Exercise of Share Options &

Total Voting Rights

Idox plc (AIM: IDOX) a leading supplier of specialist information management solutions and services, announces that it has issued 119,047 new ordinary shares of 1 pence each in the Company ("Ordinary Shares") pursuant to an exercise of options by an employee under its Long Term Incentive Plan 2019.

Application has been made for the 119,047 new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00 a.m. on or around 21 July 2020.

The total number of Ordinary Shares in issue following Admission will be 444,750,053. The Company holds 1,491,219 Ordinary Shares in treasury. Therefore the total number of Ordinary Shares with voting rights in the Company will be 443,258,834.

The above figure of 443,258,834 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

-Ends-

Enquiries:

Idox plc	+44 (0) 870 333 7101
Chris Stone, Non-Executive Chairman
David Meaden, Chief Executive
Rob Grubb, Chief Financial Officer
Peel Hunt LLP (NOMAD and Broker)	+44 (0) 20 7418 8900
Edward Knight
Nick Prowting
James Steel
MHP Communications	+ 44 (0) 203 128 8100
Reg Hoare	idox@mhpc.com
James Bavister
Amy O'Sullivan

About Idox plc

For more information see www.idoxplc.com @Idoxgroup 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCLELLFBDLXBBD